-transparent.png){kind=logo}
OBJECTIVE The arteries of aged spontaneously hypertensive rats (SHR) exhibit spontaneous electrical activity together with membrane depolarization. Vascular eicosanoid production is increased in SHR, which is further accelerated with aging. We tested the hypothesis that eicosanoids are involved in spontaneous electrical activity, membrane depolarization or both in mesenteric arteries of aged SHR. METHODS Membrane potentials were recorded with microelectrodes from the mesenteric arteries of aged (24 months and older) SHR, aged Wistar-Kyoto (WKY) rats and adult (6- to 8-month-old) SHR. RESULTS The membrane potential was less negative in aged SHR (-38.5 +/- 0.9 mV) than in either aged WKY rats or adult SHR (-49.8 +/- 0.5 and -47.2 +/- 0.6 mV, respectively; P < 0.05 for both). Spontaneous electrical activity (5-20 mV, 1-7/min) was present only in arteries of aged SHR. Spontaneous electrical activity was not affected by phentolamine, atropine or tetrodotoxin, but was abolished by indomethacin, a cyclooxygenase inhibitor, and ONO-3708, a thromboxane A2/prostaglandin H2 receptor antagonist. Furthermore, indomethacin and ONO-3708 hyperpolarized the membrane by about 5 mV in aged SHR but not in the other two groups. Spontaneous electrical activity was enhanced by a thromboxane A2 analog and prostaglandin H2, and was abolished by a Ca2+ antagonist, nicardipine, and Ca(2+)-free solution. CONCLUSIONS These findings suggest that cyclooxygenase-dependent eicosanoids contribute importantly to both spontaneous electrical activity and membrane depolarization, presumably through activation of the thromboxane A2/prostaglandin H2 receptor, in mesenteric arteries of aged SHR, and that spontaneous electrical activity is mediated by a Ca2+ influx through voltage-dependent Ca2+ channels.
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
November 1996,
Clinical and experimental hypertension (New York, N.Y. : 1993),
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
March 1977,
Circulation research,
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
October 1986,
Japanese circulation journal,
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
June 2021,
BMC complementary medicine and therapies,
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
September 1991,
European journal of pharmacology,
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
December 1979,
Acta physiologica Scandinavica,
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
January 1983,
Clinical and investigative medicine. Medecine clinique et experimentale,
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
January 1982,
Clinical and experimental hypertension. Part A, Theory and practice,
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
October 1981,
Canadian journal of physiology and pharmacology,
K Fujii, and
U Onaka, and
I Abe, and
M Fujishima
January 2005,
Hypertension (Dallas, Tex. : 1979),
